Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Response to Schmidt et al.: Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis

Fig. 1

Panel (A) compares results of the causal effect of CETP inhibition on AD risk when using four different GWAS for AD. Panel (B) compares results of the causal effect of CETP inhibition on AD risk when scaling effects to CETP concentrations, increasing HDL cholesterol, and decreasing LDL cholesterol and triglycerides (TG), using the largest AD GWAS as the outcome (Bellenguez et al., 2022)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193